Giulia realized an interest in health and pharmaceutical sciences during her first year of undergraduate studies in engineering, and subsequently transferred into BSc training in Pharmaceutical Chemistry. Giulia was awarded an internship at Bayer Inc. in the Medical and Scientific Affairs Department where she gained skills studying drugs within a range of clinical trial phases to post-marketing surveillance. Industry offered Giulia clinical experience at the population level transferable to her current goals in clinical research. After her internship, Giulia completed her undergraduate thesis research in the area of diabetes and obesity. Her studies were centered on the expression, regulation and function of a novel starvation hormone called fibroblast growth factor 21. Giulia’s research efforts in this area have resulted in a co-authored manuscript that will be submitted to The Journal of Clinical Investigation in the upcoming months. Giulia completed her BSc thesis in molecular biology, which provided her with basic science research experience, and reinforced her interests in clinical research. Post-graduation, Giulia investigated different areas of clinical research, from pharmaceutical innovation and drug target duplication in industry to the areas of pharmacoepidemiology and health economics. She was enthusiastic to combine her passion for clinical research with a relevant therapeutic area, and was immediately drawn to the efforts of Dr. Suzanne Cadarette in pharmacoepidemiology and health services research in osteoporosis and fracture prevention. Currently, Giulia is in the first year of her Master’s degree in the Division of Clinical, Social and Administrative Pharmacy in Pharmaceutical Sciences at the University of Toronto, Leslie Dan Faculty of Pharmacy.